Stay updated on DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Sign up to get notified when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.

Latest updates to the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check41 days agoChange DetectedThe page has removed a citation for a study on Ripretinib in patients with advanced gastrointestinal stromal tumors, which included an erratum reference.SummaryDifference0.3%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has been updated to include the term 'Gastrointestinal Stromal Tumors' and the study identifier 'DCC-2618-03-001', while the previous version's detailed study description and inclusion/exclusion criteria have been removed. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference32%
Stay in the know with updates to DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCC-2618 vs Placebo in Advanced GIST Patients Clinical Trial page.